Search

everythinglearnresearchcommunity

for

Search:↓

Injectable platelet-rich fibrin helps hair growth by boosting key cell functions.

LMWP-PDGFA shows promise for improving hair health and treating hair loss with fewer side effects.

The new delivery system improves treatment for hair loss by enhancing drug absorption and effectiveness.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

Finasteride in lipid carriers improved hair growth in rats.

The peptide IMT-P8 can effectively deliver proteins into the skin and cells for potential skin treatments.

Isoquercitrin helps hair grow by activating certain cell processes.

Injectable platelet-rich fibrin improves hair growth and reduces hair loss in women.

IGF-1 from human placenta helps hair grow.

The fish oil-based gel with imiquimod improves skin cancer treatment and reduces inflammation.

The gel with special fat-loaded particles from rice bran could be an effective skin treatment for hair loss.

ISX-9 helps stem cells heal lung injury better by boosting growth factor secretion.

Injectable platelet-rich fibrin therapy improved hair and scalp conditions in women with excessive hair loss.

The new gel effectively treats psoriasis with minimal side effects.

Cholesterol- and phospholipid-free niosomes improve deep skin drug delivery.

LRIG1 is linked to better survival in Merkel cell carcinoma.

Lipin-1 is important for skin cell differentiation and skin barrier function.

Two men experienced hair regrowth while being treated with immune globulin for other health issues, but there were also side effects.

Solid Lipid Particle technology makes retinol more stable, effective, and gentle on the skin.

The boy's severe skin disorder is caused by two new mutations in his TGM1 gene.

IGF-1 and EGF together significantly boost hair follicle growth in cashmere goats.

A new microneedle treatment shows promise for better hair regrowth in androgenetic alopecia.

RADA16-I can effectively deliver and release mangiferin, improving its solubility and bioavailability.

Sirolimus and propranolol may reduce abnormal cell growth and improve lymphatic malformations in children.

Modified HDL can better deliver drugs and genes, potentially improving treatments and reducing side effects.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Mutations in NIPAL4 cause skin issues by disrupting lipid layers, but some improvement is seen with topical treatment.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

A 5-year-old girl with a rare genetic disorder, lipoid proteinosis, showed reduced new lesions but persistent scars after avoiding skin trauma.